392 related articles for article (PubMed ID: 19660548)
21. Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme.
Prudencio M; Durazo A; Whitelegge JP; Borchelt DR
J Neurochem; 2009 Feb; 108(4):1009-18. PubMed ID: 19077113
[TBL] [Abstract][Full Text] [Related]
22. Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse.
Wang L; Deng HX; Grisotti G; Zhai H; Siddique T; Roos RP
Hum Mol Genet; 2009 May; 18(9):1642-51. PubMed ID: 19233858
[TBL] [Abstract][Full Text] [Related]
23. Alteration of familial ALS-linked mutant SOD1 solubility with disease progression: its modulation by the proteasome and Hsp70.
Koyama S; Arawaka S; Chang-Hong R; Wada M; Kawanami T; Kurita K; Kato M; Nagai M; Aoki M; Itoyama Y; Sobue G; Chan PH; Kato T
Biochem Biophys Res Commun; 2006 May; 343(3):719-30. PubMed ID: 16563356
[TBL] [Abstract][Full Text] [Related]
24. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis.
Jonsson PA; Ernhill K; Andersen PM; Bergemalm D; Brännström T; Gredal O; Nilsson P; Marklund SL
Brain; 2004 Jan; 127(Pt 1):73-88. PubMed ID: 14534160
[TBL] [Abstract][Full Text] [Related]
25. Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALS.
Synofzik M; Ronchi D; Keskin I; Basak AN; Wilhelm C; Gobbi C; Birve A; Biskup S; Zecca C; Fernández-Santiago R; Kaugesaar T; Schöls L; Marklund SL; Andersen PM
Hum Mol Genet; 2012 Aug; 21(16):3568-74. PubMed ID: 22595972
[TBL] [Abstract][Full Text] [Related]
26. Direct and indirect mechanisms for wild-type SOD1 to enhance the toxicity of mutant SOD1 in bigenic transgenic mice.
Xu G; Ayers JI; Roberts BL; Brown H; Fromholt S; Green C; Borchelt DR
Hum Mol Genet; 2015 Feb; 24(4):1019-35. PubMed ID: 25305079
[TBL] [Abstract][Full Text] [Related]
27. Polyanion binding accelerates the formation of stable and low-toxic aggregates of ALS-linked SOD1 mutant A4V.
Zhao D; Zhang S; Meng Y; Xiongwei D; Zhang D; Liang Y; Wang L; Liu C
Proteins; 2014 Dec; 82(12):3356-72. PubMed ID: 25220364
[TBL] [Abstract][Full Text] [Related]
28. A misfolded dimer of Cu/Zn-superoxide dismutase leading to pathological oligomerization in amyotrophic lateral sclerosis.
Anzai I; Tokuda E; Mukaiyama A; Akiyama S; Endo F; Yamanaka K; Misawa H; Furukawa Y
Protein Sci; 2017 Mar; 26(3):484-496. PubMed ID: 27977888
[TBL] [Abstract][Full Text] [Related]
29. Conversion to the amyotrophic lateral sclerosis phenotype is associated with intermolecular linked insoluble aggregates of SOD1 in mitochondria.
Deng HX; Shi Y; Furukawa Y; Zhai H; Fu R; Liu E; Gorrie GH; Khan MS; Hung WY; Bigio EH; Lukas T; Dal Canto MC; O'Halloran TV; Siddique T
Proc Natl Acad Sci U S A; 2006 May; 103(18):7142-7. PubMed ID: 16636275
[TBL] [Abstract][Full Text] [Related]
30. The accumulation of enzymatically inactive cuproenzymes is a CNS-specific phenomenon of the SOD1
Hilton JB; Kysenius K; White AR; Crouch PJ
Exp Neurol; 2018 Sep; 307():118-128. PubMed ID: 29906423
[TBL] [Abstract][Full Text] [Related]
31. Decreased stability and increased formation of soluble aggregates by immature superoxide dismutase do not account for disease severity in ALS.
Vassall KA; Stubbs HR; Primmer HA; Tong MS; Sullivan SM; Sobering R; Srinivasan S; Briere LA; Dunn SD; Colón W; Meiering EM
Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2210-5. PubMed ID: 21257910
[TBL] [Abstract][Full Text] [Related]
32. Cysteine residues in Cu,Zn-superoxide dismutase are essential to toxicity in Caenorhabditis elegans model of amyotrophic lateral sclerosis.
Ogawa M; Shidara H; Oka K; Kurosawa M; Nukina N; Furukawa Y
Biochem Biophys Res Commun; 2015 Aug; 463(4):1196-202. PubMed ID: 26086102
[TBL] [Abstract][Full Text] [Related]
33. Neuromuscular accumulation of mutant superoxide dismutase 1 aggregates in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Turner BJ; Lopes EC; Cheema SS
Neurosci Lett; 2003 Oct; 350(2):132-6. PubMed ID: 12972170
[TBL] [Abstract][Full Text] [Related]
34. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.
Zimmerman MC; Oberley LW; Flanagan SW
J Neurochem; 2007 Aug; 102(3):609-18. PubMed ID: 17394531
[TBL] [Abstract][Full Text] [Related]
35. Wild-type human SOD1 overexpression does not accelerate motor neuron disease in mice expressing murine Sod1 G86R.
Audet JN; Gowing G; Julien JP
Neurobiol Dis; 2010 Oct; 40(1):245-50. PubMed ID: 20573565
[TBL] [Abstract][Full Text] [Related]
36. Disulfide-reduced ALS variants of Cu, Zn superoxide dismutase exhibit increased populations of unfolded species.
Kayatekin C; Zitzewitz JA; Matthews CR
J Mol Biol; 2010 Apr; 398(2):320-31. PubMed ID: 20184893
[TBL] [Abstract][Full Text] [Related]
37. Folding of Cu, Zn superoxide dismutase and familial amyotrophic lateral sclerosis.
Khare SD; Ding F; Dokholyan NV
J Mol Biol; 2003 Nov; 334(3):515-25. PubMed ID: 14623191
[TBL] [Abstract][Full Text] [Related]
38. The Disulfide Bond, but Not Zinc or Dimerization, Controls Initiation and Seeded Growth in Amyotrophic Lateral Sclerosis-linked Cu,Zn Superoxide Dismutase (SOD1) Fibrillation.
Chattopadhyay M; Nwadibia E; Strong CD; Gralla EB; Valentine JS; Whitelegge JP
J Biol Chem; 2015 Dec; 290(51):30624-36. PubMed ID: 26511321
[TBL] [Abstract][Full Text] [Related]
39. An RNAi strategy for treatment of amyotrophic lateral sclerosis caused by mutant Cu,Zn superoxide dismutase.
Xia XG; Zhou H; Zhou S; Yu Y; Wu R; Xu Z
J Neurochem; 2005 Jan; 92(2):362-7. PubMed ID: 15663483
[TBL] [Abstract][Full Text] [Related]
40. Reduced net charge and heterogeneity of pI isoforms in familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase.
Roudeau S; Chevreux S; Carmona A; Ortega R
Electrophoresis; 2015 Oct; 36(19):2482-8. PubMed ID: 26084641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
